Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

ATOPIC STATUS PROTECTS FROM SEVERE COMPLICATIONS OF COVID-19
  • +8
  • Enrico Scala,
  • Damiano Abeni,
  • Alberto Tedeschi,
  • Giuseppina Manzotti,
  • Baoran Yang,
  • Paolo Borrelli,
  • Mauro Giani,
  • Alessandro Marra,
  • Antonio Sgadari,
  • Francesca Saltalamacchia,
  • Riccardo Asero
Enrico Scala
IDI - IRCCS

Corresponding Author:[email protected]

Author Profile
Damiano Abeni
IDI - IRCCS
Author Profile
Alberto Tedeschi
Ospedale Bolognini di Seriate
Author Profile
Giuseppina Manzotti
Casa di Cura Palazzolo
Author Profile
Baoran Yang
Azienda Ospedaliera Carlo Poma
Author Profile
Paolo Borrelli
Ospedale Beauregard
Author Profile
Mauro Giani
Istituto Dermopatico dell'Immacolata IRCCS
Author Profile
Alessandro Marra
ASST-Rhodense, PO Rho
Author Profile
Antonio Sgadari
Istituto Dermopatico dell'Immacolata Istituto di Ricovero e Cura a Carattere Scientifico
Author Profile
Francesca Saltalamacchia
Ospedale Bolognini di Seriate
Author Profile
Riccardo Asero
San Carlo Clinic
Author Profile

Abstract

BACKGROUND: Severe Covid-19 is associated with a cytokine storm leading to the hyper-expression of cytokines such as IFN-gamma, TNF-alpha, and IL-6, which may be responsible for most severe symptoms and signs of the disease. The immune response of the atopic patient is mostly Th2-oriented, associated with the expression of cytokines such as IL-4, IL-5, and IL-13, and atopic patients express fewer ACE-2 receptors than non-atopic individuals do. We assessed whether atopic status may protect from the most severe consequences of Covid-19. METHODS: Atopic status along with co-factors such as diabetes, hypertension, coronary heart disease, and thrombosis was investigated in severe Covid-19 patients admitted to different Italian hospitals. Patients were classified as having a mild, severe, or very severe disease based on the need of respiratory assistance; severity was plotted against the different co-factors and underwent multivariate analysis. RESULTS: 531 adults aged 25 - 100 years were studied; 57 (11.7%) were atopic. Atopic status showed a significant association with a milder disease irrespective of all other co-factors considered (p <0.001); the protective effect of atopy was detectable throughout all age groups (p< 0.001). CONCLUSIONS: Atopic status appears to protect from the most severe consequences of Covid-19.
16 Aug 2020Published in Allergy. 10.1111/all.14551